← Every company
Teva Pharmaceutical Industries Ltd Lobbying
What Teva Pharmaceutical Industries Ltd discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
TEVA on carbonthat →Disclosed spend
$2.1M
across every filing on file
Filings
11
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesCopyright/Patent/TrademarkTariff (miscellaneous tariff bills)ManufacturingPharmacyMedicare/Medicaid
11 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | TEVA PHARMACEUTICALS USA, INC.Health IssuesTariff (miscellaneous tariff bills) | $1.1M |
| 20262nd Quarter (Apr 1 - June 30) | TEVA PHARMACEUTICALS USA, INC.Health IssuesTariff (miscellaneous tariff bills) | $380K |
| 20261st Quarter (Jan 1 - Mar 31) | MR. DAVID FRIEDMANManufacturingPharmacy | $250K |
| 20262nd Quarter (Apr 1 - June 30) | MR. DAVID FRIEDMAN | $100K |
| 20261st Quarter (Jan 1 - Mar 31) | TALLEY STRATEGIES LLC | $60K |
| 20262nd Quarter (Apr 1 - June 30) | CAPITOL HILL CONSULTING GROUPHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | FAEGRE DRINKER BIDDLE & REATH LLPHealth IssuesCopyright/Patent/Trademark | $60K |
| 20262nd Quarter (Apr 1 - June 30) | FAEGRE DRINKER BIDDLE & REATH LLPHealth IssuesCopyright/Patent/Trademark | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL HILL CONSULTING GROUPHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TALLEY STRATEGIES LLC | — |
| 20263rd Quarter (July 1 - Sep 30) | TALLEY STRATEGIES LLC | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on TEVA
Company overviewEverything on TEVA in one place, with the price.SEC filingsWhat TEVA's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat TEVA's own officers and directors buy and sell.Planned salesSales TEVA insiders have filed notice of.Who lobbies for itThe lobbyists on TEVA's account, and who they worked for.Federal contractsWhat federal agencies pay TEVA.PatentsWhat TEVA is filing at the patent office.